{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:04:19Z","timestamp":1783811059823,"version":"3.55.0"},"reference-count":262,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:00:00Z","timestamp":1598054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:00:00Z","timestamp":1598054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00109-020-01965-0","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T04:02:27Z","timestamp":1598068947000},"page":"1397-1414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Revisiting lactate dynamics in cancer\u2014a metabolic expertise or an alternative attempt to survive?"],"prefix":"10.1007","volume":"98","author":[{"given":"Cindy","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1548-5907","authenticated-orcid":false,"given":"Jacinta","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,22]]},"reference":[{"key":"1965_CR1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.clinbiochem.2008.06.011","volume":"41","author":"JP Talasniemi","year":"2008","unstructured":"Talasniemi JP, Pennanen S, Savolainen H et al (2008) Analytical investigation: assay of d-lactate in diabetic plasma and urine. Clin Biochem 41:1099\u20131103","journal-title":"Clin Biochem"},{"key":"1965_CR2","doi-asserted-by":"publisher","unstructured":"Monroe GR, van Eerde AM, Tessadori F, et al (2019) Identification of human D lactate dehydrogenase deficiency. Nat Commun 1477. https:\/\/doi.org\/10.1038\/s41467-019-09458-6","DOI":"10.1038\/s41467-019-09458-6"},{"key":"1965_CR3","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1152\/ajpendo.1995.269.3.E443","volume":"269","author":"G Perriello","year":"1995","unstructured":"Perriello G, Jorde R, Nurjhan N et al (1995) Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle. Am J Physiol Endocrinol Metab 269:E443\u2013E450","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1965_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mito.2014.05.007","volume":"17","author":"M Adeva-Andany","year":"2014","unstructured":"Adeva-Andany M, L\u00f3pez-Oj\u00e9n M, Funcasta-Calder\u00f3n R et al (2014) Comprehensive review on lactate metabolism in human health. Mitochondrion 17:76\u2013100","journal-title":"Mitochondrion"},{"key":"1965_CR5","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-019-13485-8","volume":"10","author":"A Cheng","year":"2019","unstructured":"Cheng A, Zhang P, Wang B et al (2019) Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect. Nat Commun 10:5566","journal-title":"Nat Commun"},{"key":"1965_CR6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#","volume":"43","author":"JA Read","year":"2001","unstructured":"Read JA, Winter VJ, Eszes CM et al (2001) Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins Struct Funct Genet 43:175\u2013185","journal-title":"Proteins Struct Funct Genet"},{"key":"1965_CR7","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","volume":"107","author":"A Le","year":"2010","unstructured":"Le A, Cooper CR, Gouw AM et al (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107:2037\u20132042","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1965_CR8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/BJ20081132","volume":"417","author":"M Thangaraju","year":"2008","unstructured":"Thangaraju M, Carswell KN, Prasad PD, Ganapathy V (2008) Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1\/HDAC3. Biochem J 417:379\u2013389","journal-title":"Biochem J"},{"key":"1965_CR9","doi-asserted-by":"publisher","unstructured":"Serpa J (2020) Metabolic remodeling as a way of adapting to tumor microenvironment (TME), a job of several holders. Adv Exp Med Biol:1\u201334. https:\/\/doi.org\/10.1007\/978-3-030-34025-4_1","DOI":"10.1007\/978-3-030-34025-4_1"},{"key":"1965_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2017.00038","volume":"5","author":"HM Haikala","year":"2017","unstructured":"Haikala HM, Anttila JM, Klefstr\u00f6m J (2017) MYC and AMPK\u2013save energy or die! Front Cell Dev Biol 5:1\u201312","journal-title":"Front Cell Dev Biol"},{"key":"1965_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0891-5849(01)00759-6","volume":"32","author":"M Mar\u00ed","year":"2002","unstructured":"Mar\u00ed M, Bai J, Cederbaum AI (2002) Toxicity by pyruvate in HepG2 cells depleted of glutathione: role of mitochondria. Free Radic Biol Med 32:73\u201383","journal-title":"Free Radic Biol Med"},{"key":"1965_CR12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1084\/jem.165.2.500","volume":"165","author":"J O\u2019donnell-Tormey","year":"1987","unstructured":"O\u2019donnell-Tormey J, Nathan CF, Lanks K et al (1987) Secretion of pyruvate: an antioxidant defense of mammalian cells. J Exp Med 165:500\u2013514","journal-title":"J Exp Med"},{"key":"1965_CR13","doi-asserted-by":"crossref","first-page":"15947","DOI":"10.1074\/jbc.RA118.004180","volume":"293","author":"M \u017ddralevi\u0107","year":"2018","unstructured":"\u017ddralevi\u0107 M, Brand A, Di IL et al (2018) Double genetic disruption of lactate dehydrogenases A and B is required to ablate the \u201cWarburg effect\u201d restricting tumor growth to oxidative metabolism. J Biol Chem 293:15947\u201315961","journal-title":"J Biol Chem"},{"key":"1965_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jb\/mvy108","volume":"165","author":"M Dodo","year":"2019","unstructured":"Dodo M, Kitamura H, Shima H et al (2019) Lactate dehydrogenase C is required for the protein expression of a sperm-specific isoform of lactate dehydrogenase A. J Biochem 165:323\u2013334","journal-title":"J Biochem"},{"key":"1965_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2164\/jandrol.108.005785","volume":"30","author":"H Tang","year":"2009","unstructured":"Tang H, Goldberg E (2009) Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation. J Androl 30:157\u2013167","journal-title":"J Androl"},{"key":"1965_CR16","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.3892\/mmr.2016.4963","volume":"13","author":"L Kong","year":"2016","unstructured":"Kong L, Du W, Cui Z et al (2016) Expression of lactate dehydrogenase C in MDA-MB-231 cells and its role in tumor invasion and migration. Mol Med Rep 13:3533\u20133538","journal-title":"Mol Med Rep"},{"key":"1965_CR17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00432-014-1719-y","volume":"140","author":"K Chen","year":"2014","unstructured":"Chen K, Zhu C, Cai M et al (2014) Integrative metabolome and transcriptome profiling reveals discordant glycolysis process between osteosarcoma and normal osteoblastic cells. J Cancer Res Clin Oncol 140:1715\u20131721","journal-title":"J Cancer Res Clin Oncol"},{"key":"1965_CR18","first-page":"6750","volume":"62","author":"M Koslowski","year":"2002","unstructured":"Koslowski M, T\u00fcreci \u00d6, Bell C et al (2002) Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res 62:6750\u20136755","journal-title":"Cancer Res"},{"key":"1965_CR19","doi-asserted-by":"publisher","unstructured":"Hua Y, Liang C, Zhu J et al (2017) Expression of lactate dehydrogenase C correlates with poor prognosis in renal cell carcinoma. Tumor Biol 39. https:\/\/doi.org\/10.1177\/1010428317695968","DOI":"10.1177\/1010428317695968"},{"key":"1965_CR20","doi-asserted-by":"crossref","first-page":"e0741","DOI":"10.1097\/MD.0000000000010741","volume":"97","author":"Y Fu","year":"2018","unstructured":"Fu Y, Lan T, Cai H et al (2018) Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma. Med 97:e0741","journal-title":"Med"},{"key":"1965_CR21","doi-asserted-by":"publisher","unstructured":"Zhang J, Yao YH, Li BG et al (2015) Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis. Sci Rep:9800. https:\/\/doi.org\/10.1038\/srep09800","DOI":"10.1038\/srep09800"},{"key":"1965_CR22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/cam4.2024","volume":"8","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Li Y, Yan X et al (2019) Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Cancer Med 8:1467\u20131473","journal-title":"Cancer Med"},{"key":"1965_CR23","doi-asserted-by":"publisher","unstructured":"ming HX, qiao YS, Zhao D et al (2019) LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma. Biosci Rep 39. https:\/\/doi.org\/10.1042\/BSR20181476","DOI":"10.1042\/BSR20181476"},{"key":"1965_CR24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1158\/1078-0432.CCR-12-2638","volume":"19","author":"ML McCleland","year":"2013","unstructured":"McCleland ML, Adler AS, Deming L et al (2013) Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas. Clin Cancer Res 19:773\u2013784","journal-title":"Clin Cancer Res"},{"key":"1965_CR25","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.onc.1206302","volume":"22","author":"S Rodriguez","year":"2003","unstructured":"Rodriguez S, Jafer O, Goker H et al (2003) Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene 22:1880\u20131891","journal-title":"Oncogene"},{"key":"1965_CR26","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1038\/sj.onc.1209262","volume":"25","author":"A Leiblich","year":"2006","unstructured":"Leiblich A, Cross SS, Catto JWF et al (2006) Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer. Oncogene 25:2953\u20132960","journal-title":"Oncogene"},{"key":"1965_CR27","first-page":"4710","volume":"17","author":"A Nagamine","year":"2019","unstructured":"Nagamine A, Araki T, Nagano D et al (2019) L-lactate dehydrogenase B may be a predictive marker for sensitivity to anti-EGFR monoclonal antibodies in colorectal cancer cell lines. Oncol Lett 17:4710\u20134716","journal-title":"Oncol Lett"},{"key":"1965_CR28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41467-018-07857-9","volume":"10","author":"A Flores","year":"2019","unstructured":"Flores A, Sandoval-Gonzalez S, Takahashi R et al (2019) Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin. Nat Commun 10:91","journal-title":"Nat Commun"},{"key":"1965_CR29","doi-asserted-by":"publisher","unstructured":"Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J:281\u2013299. https:\/\/doi.org\/10.1042\/0264-6021:3430281","DOI":"10.1042\/0264-6021:3430281"},{"key":"1965_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.573","volume":"64","author":"AP Halestrap","year":"2012","unstructured":"Halestrap AP (2012) The monocarboxylate transporter family-Structure and functional characterization. IUBMB Life 64:1\u20139","journal-title":"IUBMB Life"},{"key":"1965_CR31","doi-asserted-by":"publisher","unstructured":"Romero-Garcia S, Moreno-Altamirano MMB, Prado-Garcia H, S\u00e1nchez-Garc\u00eda FJ (2016) Lactate contribution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevance. Front Immunol 7(52). https:\/\/doi.org\/10.3389\/fimmu.2016.00052","DOI":"10.3389\/fimmu.2016.00052"},{"key":"1965_CR32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/fon.09.145","volume":"6","author":"KM Kennedy","year":"2010","unstructured":"Kennedy KM, Dewhirst MW (2010) Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol 6:127\u2013148","journal-title":"Future Oncol"},{"key":"1965_CR33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2407-11-312","volume":"11","author":"N P\u00e9rtega-Gomes","year":"2011","unstructured":"P\u00e9rtega-Gomes N, Vizca\u00edno JR, Miranda-Gon\u00e7alves V et al (2011) Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. BMC Cancer 11:312","journal-title":"BMC Cancer"},{"key":"1965_CR34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2559.2010.03560.x","volume":"56","author":"C Pinheiro","year":"2010","unstructured":"Pinheiro C, Albergaria A, Paredes J et al (2010) Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56:860\u2013867","journal-title":"Histopathology"},{"key":"1965_CR35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10863-012-9428-1","volume":"44","author":"C Pinheiro","year":"2012","unstructured":"Pinheiro C, Longatto-Filho A, Azevedo-Silva J et al (2012) Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 44:127\u2013139","journal-title":"J Bioenerg Biomembr"},{"key":"1965_CR36","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4161\/cc.24092","volume":"12","author":"JM Curry","year":"2013","unstructured":"Curry JM, Tuluc M, Whitaker-Menezes D et al (2013) Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle 12:1371\u20131384","journal-title":"Cell Cycle"},{"key":"1965_CR37","doi-asserted-by":"crossref","first-page":"82803","DOI":"10.18632\/oncotarget.20294","volume":"8","author":"F Lopes-Coelho","year":"2017","unstructured":"Lopes-Coelho F, Nunes C, Gouveia-Fernandes S et al (2017) Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells. Oncotarget 8:82803\u201382823","journal-title":"Oncotarget"},{"key":"1965_CR38","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1007\/s13277-015-4385-z","volume":"37","author":"LS Silva","year":"2016","unstructured":"Silva LS, Goncalves LG, Silva F et al (2016) STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment. Tumor Biol 37:5385\u20135395","journal-title":"Tumor Biol"},{"key":"1965_CR39","first-page":"1967","volume":"8","author":"SJ Park","year":"2018","unstructured":"Park SJ, Smith CP, Wilbur RR et al (2018) An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications. Am J Cancer Res 8:1967\u20131976","journal-title":"Am J Cancer Res"},{"key":"1965_CR40","doi-asserted-by":"crossref","first-page":"e2915","DOI":"10.1371\/journal.pone.0002915","volume":"3","author":"T Hashimoto","year":"2008","unstructured":"Hashimoto T, Hussien R, Cho HS et al (2008) Evidence for the mitochondrial lactate oxidation complex in rat neurons: demonstration of an essential component of brain lactate shuttles. PLoS One 3:e2915","journal-title":"PLoS One"},{"key":"1965_CR41","doi-asserted-by":"crossref","first-page":"E571","DOI":"10.1152\/ajpendo.2000.278.4.E571","volume":"278","author":"H Dubouchaud","year":"2000","unstructured":"Dubouchaud H, Butterfield GE, Wolfel EE et al (2000) Endurance training, expression, and physiology of LDH, MCT1, and MCT4 in human skeletal muscle. Am J Physiol Endocrinol Metab 278:E571\u2013E579","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1965_CR42","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1113\/jphysiol.2009.178350","volume":"587","author":"GA Brooks","year":"2009","unstructured":"Brooks GA (2009) Cell-cell and intracellular lactate shuttles. J Physiol 587:5591\u20135600","journal-title":"J Physiol"},{"issue":"Pt 1","key":"1965_CR43","first-page":"121","volume":"567","author":"CR Benton","year":"2004","unstructured":"Benton CR, Campbell SE, Tonouchi M et al (2004) Monocarboxylate transporters in subsarcolemmal and intermyofibrillar mitochondria. Biochem Biophys Res Commun 567(Pt 1):121\u2013129","journal-title":"Biochem Biophys Res Commun"},{"key":"1965_CR44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1152\/japplphysiol.00009.2004","volume":"97","author":"CE Butz","year":"2004","unstructured":"Butz CE, McClelland GB, Brooks GA (2004) MCT1 confirmed in rat striated muscle mitochondria. J Appl Physiol 97:1059\u20131066","journal-title":"J Appl Physiol"},{"key":"1965_CR45","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1152\/jappl.1999.87.5.1713","volume":"87","author":"GA Brooks","year":"1999","unstructured":"Brooks GA, Brown MA, Butz CE et al (1999) Cardiac and skeletal muscle mitochondria have a monocarboxylate transporter MCT1. J Appl Physiol 87:1713\u20131718","journal-title":"J Appl Physiol"},{"key":"1965_CR46","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1534\/genetics.117.300262","volume":"207","author":"AM Van Der Bliek","year":"2017","unstructured":"Van Der Bliek AM, Sedensky MM, Morgan PG (2017) Cell biology of the mitochondrion. Genetics 207:843\u2013871","journal-title":"Genetics"},{"key":"1965_CR47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molmet.2019.08.021","volume":"33","author":"P Kreuzaler","year":"2019","unstructured":"Kreuzaler P, Panina Y, Segal J, Yuneva M (2019) Adapt and conquer: metabolic flexibility in cancer growth, invasion and evasion. Mol Metab 33:83\u2013101","journal-title":"Mol Metab"},{"key":"1965_CR48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1748-1716.2010.02122.x","volume":"199","author":"G Van Hall","year":"2010","unstructured":"Van Hall G (2010) Lactate kinetics in human tissues at rest and during exercise. Acta Physiol 199:499\u2013508","journal-title":"Acta Physiol"},{"key":"1965_CR49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1242\/dev.138545","volume":"144","author":"H Miyazawa","year":"2017","unstructured":"Miyazawa H, Yamaguchi Y, Sugiura Y et al (2017) Rewiring of embryonic glucose metabolism via suppression of PFK-1 and aldolase during mouse chorioallantoic branching. Dev 144:63\u201373","journal-title":"Dev"},{"key":"1965_CR50","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.189365.112","volume":"26","author":"CV Dang","year":"2012","unstructured":"Dang CV (2012) Links between metabolism and cancer. Genes Dev 26:877\u2013890","journal-title":"Genes Dev"},{"key":"1965_CR51","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1249\/00005768-198606000-00019","volume":"18","author":"GA Brooks","year":"1986","unstructured":"Brooks GA (1986) The lactate shuttle during exercise and recovery. Med Sci Sports Exerc 18:360\u2013368","journal-title":"Med Sci Sports Exerc"},{"key":"1965_CR52","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.2000.278.2.E244","volume":"278","author":"BC Bergman","year":"2000","unstructured":"Bergman BC, Horning MA, Casazza GA et al (2000) Endurance training increases gluconeogenesis during rest and exercise in men. Am J Physiol Endocrinol Metab 278:E244\u2013E251","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1965_CR53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","volume":"26","author":"L Liu","year":"2017","unstructured":"Liu L, MacKenzie KR, Putluri N et al (2017) The glia-neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D. Cell Metab 26:719\u2013737.e6","journal-title":"Cell Metab"},{"key":"1965_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1113\/jphysiol.2003.058701","volume":"558","author":"LB Gladden","year":"2004","unstructured":"Gladden LB (2004) Lactate metabolism: a new paradigm for the third millennium. J Physiol 558:5\u201330","journal-title":"J Physiol"},{"key":"1965_CR55","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/jnr.10081","volume":"66","author":"AM Brown","year":"2001","unstructured":"Brown AM, Wender R, Ransom BR (2001) Metabolic substrates other than glucose support axon function in central white matter. J Neurosci Res 66:839\u2013843","journal-title":"J Neurosci Res"},{"key":"1965_CR56","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1152\/jappl.1999.87.5.1684","volume":"87","author":"BC Bergman","year":"1999","unstructured":"Bergman BC, Wolfel EE, Butterfield GE et al (1999) Active muscle and whole body lactate kinetics after endurance training in men. J Appl Physiol 87:1684\u20131696","journal-title":"J Appl Physiol"},{"key":"1965_CR57","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1113\/jphysiol.2008.168286","volume":"587","author":"BC Bergman","year":"2009","unstructured":"Bergman BC, Tsvetkova T, Lowes B, Wolfel EE (2009) Myocardial glucose and lactate metabolism during rest and atrial pacing in humans. J Physiol 587:2087\u20132099","journal-title":"J Physiol"},{"key":"1965_CR58","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1096\/fj.201700381RR","volume":"32","author":"T Hashimoto","year":"2018","unstructured":"Hashimoto T, Tsukamoto H, Takenaka S et al (2018) Maintained exercise-enhanced brain executive function related to cerebral lactate metabolism in men. FASEB J 32:1417\u20131427","journal-title":"FASEB J"},{"key":"1965_CR59","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1038\/s41598-018-28249-5","volume":"8","author":"J Lund","year":"2018","unstructured":"Lund J, Aas V, Tingstad RH et al (2018) Utilization of lactic acid in human myotubes and interplay with glucose and fatty acid metabolism. Sci Rep 8:9814","journal-title":"Sci Rep"},{"key":"1965_CR60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1931.11.2.143","volume":"11","author":"CF Cori","year":"1931","unstructured":"Cori CF (1931) Mammalian carbohydrate metabolism. Physiol Rev 11:143\u2013275","journal-title":"Physiol Rev"},{"key":"1965_CR61","first-page":"29","volume":"16","author":"GABG Gaesser","year":"1984","unstructured":"Gaesser GABG (1984) Metabolic bases of excess post-exercise oxygen consumption: a review. Med Sci Sports Exerc 16:29\u201343","journal-title":"Med Sci Sports Exerc"},{"key":"1965_CR62","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1249\/00005768-199108000-00006","volume":"23","author":"WC Stanley","year":"1991","unstructured":"Stanley WC (1991) Myocardial lactate metabolism during exercise. Med Sci Sports Exerc 23:920\u2013924","journal-title":"Med Sci Sports Exerc"},{"key":"1965_CR63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s004210100516","volume":"86","author":"A Bonen","year":"2001","unstructured":"Bonen A (2001) The expression of lactate transporters (MCT1 and MCT4) in heart and muscle. Eur J Appl Physiol 86:6\u201311","journal-title":"Eur J Appl Physiol"},{"key":"1965_CR64","first-page":"E143","volume":"271","author":"KJA McCullagh","year":"1996","unstructured":"McCullagh KJA, Poole RC, Halestrap AP et al (1996) Role of the lactate transporter (MCT1) in skeletal muscles. Am J Phys 271:E143\u2013E150","journal-title":"Am J Phys"},{"key":"1965_CR65","first-page":"3930","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"Sonveaux P, V\u00e9gran F, Schroeder T et al (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930\u20133942","journal-title":"J Clin Invest"},{"key":"1965_CR66","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-10-2828","volume":"71","author":"F V\u00e9gran","year":"2011","unstructured":"V\u00e9gran F, Boidot R, Michiels C et al (2011) Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kB\/IL-8 pathway that drives tumor angiogenesis. Cancer Res 71:2550\u20132560","journal-title":"Cancer Res"},{"key":"1965_CR67","unstructured":"Walenta S, Wetterling M, Lehrke M et al (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res:916\u2013921"},{"key":"1965_CR68","doi-asserted-by":"publisher","unstructured":"Brizel DM, Schroeder T, Scher RL et al (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys:349\u2013353. https:\/\/doi.org\/10.1016\/S0360-3016(01)01630-3","DOI":"10.1016\/S0360-3016(01)01630-3"},{"key":"1965_CR69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40170-019-0199-6","volume":"7","author":"ED Montal","year":"2019","unstructured":"Montal ED, Bhalla K, Dewi RE et al (2019) Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer. Cancer Metab 7:8","journal-title":"Cancer Metab"},{"key":"1965_CR70","doi-asserted-by":"crossref","unstructured":"Faubert B, Li KY, Cai L, et al (2017) Lactate metabolism in human lung tumors. Cell 171:358-371.e9.","DOI":"10.1016\/j.cell.2017.09.019"},{"key":"1965_CR71","first-page":"406","volume":"13","author":"I Nenu","year":"2017","unstructured":"Nenu I, Gafencu GA, Popescu T, Kacso G (2017) Lactate - a new frontier in the immunology and therapy of prostate cancer. J Cancer Res Ther 13:406\u2013411","journal-title":"J Cancer Res Ther"},{"key":"1965_CR72","doi-asserted-by":"crossref","first-page":"10714","DOI":"10.18632\/oncotarget.24246","volume":"9","author":"Z Jia","year":"2018","unstructured":"Jia Z, Zhang J, Wang Z et al (2018) An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer. Oncotarget 9:10714\u201310722","journal-title":"Oncotarget"},{"key":"1965_CR73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ctrv.2010.05.001","volume":"37","author":"DW Siemann","year":"2011","unstructured":"Siemann DW (2011) The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents. Cancer Treat Rev 37:63\u201374","journal-title":"Cancer Treat Rev"},{"key":"1965_CR74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/path.3978","volume":"227","author":"H Wu","year":"2012","unstructured":"Wu H, Ding Z, Hu D et al (2012) Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death. J Pathol 227:189\u2013199","journal-title":"J Pathol"},{"key":"1965_CR75","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1038\/srep04927","volume":"4","author":"J Xie","year":"2014","unstructured":"Xie J, Wu H, Dai C et al (2014) Beyond Warburg effect - dual metabolic nature of cancer cells. Sci Rep 4:4927","journal-title":"Sci Rep"},{"key":"1965_CR76","doi-asserted-by":"crossref","first-page":"e63054","DOI":"10.1371\/journal.pone.0063054","volume":"8","author":"C Dai","year":"2013","unstructured":"Dai C, Sun F, Zhu C, Hu X (2013) Tumor environmental factors glucose deprivation and lactic acidosis induce mitotic chromosomal instability - an implication in aneuploid human tumors. PLoS One 8:e63054","journal-title":"PLoS One"},{"key":"1965_CR77","doi-asserted-by":"publisher","unstructured":"Wu H, Ying M, Hu X (2016) Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.9746","DOI":"10.18632\/oncotarget.9746"},{"key":"1965_CR78","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1249\/MSS.0b013e31815fa580","volume":"40","author":"LB Gladden","year":"2008","unstructured":"Gladden LB (2008) A \u201clactatic\u201d perspective on metabolism. Med Sci Sports Exerc 40:477\u2013485","journal-title":"Med Sci Sports Exerc"},{"key":"1965_CR79","doi-asserted-by":"crossref","first-page":"E677","DOI":"10.1152\/ajpendo.1990.259.5.E677","volume":"259","author":"A Consoli","year":"1990","unstructured":"Consoli A, Nurjhan N, Reilly JJ et al (1990) Contribution of liver and skeletal muscle to alanine and lactate metabolism in humans. Am J Physiol Endocrinol Metab 259:E677\u2013E684","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1965_CR80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41:211\u2013218","journal-title":"Trends Biochem Sci"},{"key":"1965_CR81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","volume":"43","author":"WJ Israelsen","year":"2015","unstructured":"Israelsen WJ, Vander Heiden MG (2015) Pyruvate kinase: function, regulation and role in cancer. Semin Cell Dev Biol 43:43\u201351","journal-title":"Semin Cell Dev Biol"},{"key":"1965_CR82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Giannoni E, Chiarugi P (2019) Lactate: a metabolic driver in the tumour landscape. Trends Biochem Sci 44:153\u2013166","journal-title":"Trends Biochem Sci"},{"key":"1965_CR83","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1074\/jbc.RA118.006095","volume":"294","author":"SM Hong","year":"2019","unstructured":"Hong SM, Lee YK, Park I et al (2019) Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis. J Biol Chem 294:7810\u20137820","journal-title":"J Biol Chem"},{"key":"1965_CR84","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13402-019-00426-2","volume":"42","author":"J Afonso","year":"2019","unstructured":"Afonso J, Pinto T, Sim\u00f5es-Sousa S et al (2019) Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma \u2013 MCT1 as potential target in diffuse large B cell lymphoma. Cell Oncol 42:303\u2013318","journal-title":"Cell Oncol"},{"key":"1965_CR85","doi-asserted-by":"publisher","unstructured":"Baltazar F, Afonso J, Costa M, Granja S (2020) Lactate beyond a waste metabolite: metabolic affairs and signaling in malignancy. Front Oncol 10:231. https:\/\/doi.org\/10.3389\/fonc.2020.00231","DOI":"10.3389\/fonc.2020.00231"},{"key":"1965_CR86","doi-asserted-by":"crossref","first-page":"41928","DOI":"10.1074\/jbc.M508718200","volume":"280","author":"H Lu","year":"2005","unstructured":"Lu H, Dalgard CL, Mohyeldin A et al (2005) Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 280:41928\u201341239","journal-title":"J Biol Chem"},{"key":"1965_CR87","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2015.03.011","volume":"161","author":"DC Lee","year":"2015","unstructured":"Lee DC, Sohn HA, Park ZY et al (2015) A lactate-induced response to hypoxia. Cell 161:595\u2013609","journal-title":"Cell"},{"key":"1965_CR88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/15384101.2015.1120930","volume":"15","author":"J P\u00e9rez-Escuredo","year":"2016","unstructured":"P\u00e9rez-Escuredo J, Dadhich RK, Dhup S et al (2016) Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle 15:72\u201383","journal-title":"Cell Cycle"},{"key":"1965_CR89","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, Mancuso A, Daikhin E et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 104:19345\u201319350","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1965_CR90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-34025-4_3","volume":"1219","author":"A Pereira-Nunes","year":"2020","unstructured":"Pereira-Nunes A, Afonso J, Granja S, Baltazar F (2020) Lactate and lactate transporters as key players in the maintenance of the Warburg effect. Adv Exp Med Biol 1219:51\u201374","journal-title":"Adv Exp Med Biol"},{"key":"1965_CR91","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2967\/jnumed.115.158808","volume":"57","author":"C Spick","year":"2016","unstructured":"Spick C, Herrmann K, Czernin J (2016) 18F-FDG PET\/CT and PET\/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients. J Nucl Med 57:420\u2013430","journal-title":"J Nucl Med"},{"key":"1965_CR92","doi-asserted-by":"crossref","first-page":"24415","DOI":"10.18632\/oncotarget.14705","volume":"8","author":"VF Van H\u00e9e","year":"2017","unstructured":"Van H\u00e9e VF, Labar D, Dehon G et al (2017) Radiosynthesis and validation of (\u00b1)-[18F]-3-fluoro-2- hydroxypropionate ([18F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors. Oncotarget 8:24415\u201324428","journal-title":"Oncotarget"},{"key":"1965_CR93","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","volume":"71","author":"F Hirschhaeuser","year":"2011","unstructured":"Hirschhaeuser F, Sattler UGA, Mueller-Klieser W (2011) Lactate: a metabolic key player in cancer. Cancer Res 71:6921\u20136925","journal-title":"Cancer Res"},{"key":"1965_CR94","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1158\/1535-7163.MCT-15-0217","volume":"14","author":"VC Sandulache","year":"2015","unstructured":"Sandulache VC, Chen Y, Skinner HD et al (2015) Acute tumor lactate perturbations as a biomarker of genotoxic stress: development of a biochemical model. Mol Cancer Ther 14:2901\u20132908","journal-title":"Mol Cancer Ther"},{"key":"1965_CR95","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF01712130","volume":"2","author":"O Warburg","year":"1923","unstructured":"Warburg O, Minami S (1923) Versuche an \u00dcberlebendem Carcinomgewebe. Klin Wochenschr 2:776\u2013777","journal-title":"Klin Wochenschr"},{"key":"1965_CR96","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029\u20131033","journal-title":"Science"},{"key":"1965_CR97","first-page":"309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells on the origin of cancer. Source Sci New Ser 123:309\u2013314","journal-title":"Source Sci New Ser"},{"key":"1965_CR98","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","volume":"274","author":"R Moreno-S\u00e1nchez","year":"2007","unstructured":"Moreno-S\u00e1nchez R, Rodr\u00edguez-Enr\u00edquez S, Mar\u00edn-Hern\u00e1ndez A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274:1393\u20131418","journal-title":"FEBS J"},{"key":"1965_CR99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11\u201320","journal-title":"Cell Metab"},{"key":"1965_CR100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-cancerbio-030419-033556","volume":"4","author":"SK Parks","year":"2020","unstructured":"Parks SK, Mueller-Klieser W, Pouyss\u00e9gur J (2020) Lactate and acidity in the cancer microenvironment. Annu Rev Cancer Biol 4:141\u2013158","journal-title":"Annu Rev Cancer Biol"},{"key":"1965_CR101","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/bj2500383","volume":"250","author":"R Curi","year":"1988","unstructured":"Curi R, Newsholme P, Newsholme EA (1988) Metabolism of pyruvate by isolated rat mesenteric lymphocytes, lymphocyte mitochondria and isolated mouse macrophages. Biochem J 250:383\u2013388","journal-title":"Biochem J"},{"key":"1965_CR102","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, Deberardinis RJ (2017) Understanding the Intersections between metabolism and cancer biology. Cell 168:657\u2013669","journal-title":"Cell"},{"key":"1965_CR103","doi-asserted-by":"crossref","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ De Berardinis","year":"2016","unstructured":"De Berardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2:e1600200","journal-title":"Sci Adv"},{"key":"1965_CR104","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2013.09.025","volume":"155","author":"WJ Israelsen","year":"2013","unstructured":"Israelsen WJ, Dayton TL, Davidson SM et al (2013) PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155:397\u2013409","journal-title":"Cell"},{"key":"1965_CR105","doi-asserted-by":"publisher","unstructured":"Zu XL, Guppy M (2004) Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313(3):459\u201365. https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.136","DOI":"10.1016\/j.bbrc.2003.11.136"},{"key":"1965_CR106","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1038\/ncomms9784","volume":"6","author":"C Lussey-Lepoutre","year":"2015","unstructured":"Lussey-Lepoutre C, Hollinshead KER, Ludwig C et al (2015) Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism. Nat Commun 6:8784","journal-title":"Nat Commun"},{"key":"1965_CR107","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ncb3233","volume":"17","author":"S Cardaci","year":"2015","unstructured":"Cardaci S, Zheng L, Mackay G et al (2015) Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis. Nat Cell Biol 17:1317\u20131326","journal-title":"Nat Cell Biol"},{"key":"1965_CR108","doi-asserted-by":"crossref","first-page":"62726","DOI":"10.18632\/oncotarget.10911","volume":"7","author":"M Tarrado-Castellarnau","year":"2016","unstructured":"Tarrado-Castellarnau M, de Atauri P, Cascante M (2016) Oncogenic regulation of tumor metabolic reprogramming. Oncotarget 7:62726\u201362753","journal-title":"Oncotarget"},{"key":"1965_CR109","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1007\/s00018-008-8224-x","volume":"65","author":"SJ Yeung","year":"2008","unstructured":"Yeung SJ, Pan J, Lee MH (2008) Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell Mol Life Sci 65:3981\u20133999","journal-title":"Cell Mol Life Sci"},{"key":"1965_CR110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11:85\u201395","journal-title":"Nat Rev Cancer"},{"key":"1965_CR111","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1152\/ajpendo.00027.2012","volume":"303","author":"K Gohil","year":"2012","unstructured":"Gohil K, Brooks GA (2012) Exercise tames the wild side of the Myc network: a hypothesis. Am J Physiol Endocrinol Metab 303:E18\u2013E30","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1965_CR112","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou I, Cairns RA, Fontana L et al (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187\u2013197","journal-title":"Cell Metab"},{"key":"1965_CR113","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"J Kim","year":"2006","unstructured":"Kim J, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177\u2013185","journal-title":"Cell Metab"},{"key":"1965_CR114","first-page":"119","volume":"38","author":"I San-Mill\u00e1n","year":"2017","unstructured":"San-Mill\u00e1n I, Brooks GA (2017) Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect. Carcinogenesis 38:119\u2013133","journal-title":"Carcinogenesis"},{"key":"1965_CR115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/joe.1.05599","volume":"183","author":"M Hayashi","year":"2004","unstructured":"Hayashi M, Sakata M, Takeda T et al (2004) Induction of glucose transporter 1 expression through hypoxia-inducible factor 1\u03b1 under hypoxic conditions in trophoblast-derived cells. J Endocrinol 183:145\u2013154","journal-title":"J Endocrinol"},{"key":"1965_CR116","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jbspin.2007.05.012","volume":"75","author":"BF Ren","year":"2008","unstructured":"Ren BF, Deng LF, Wang J et al (2008) Hypoxia regulation of facilitated glucose transporter-1 and glucose transporter-3 in mouse chondrocytes mediated by HIF-1\u03b1. Jt Bone Spine 75:176\u2013181","journal-title":"Jt Bone Spine"},{"key":"1965_CR117","doi-asserted-by":"crossref","first-page":"21797","DOI":"10.1074\/jbc.C000023200","volume":"275","author":"RC Osthus","year":"2000","unstructured":"Osthus RC, Shim H, Kim S et al (2000) Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 275:21797\u201321800","journal-title":"J Biol Chem"},{"key":"1965_CR118","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tibs.2012.04.002","volume":"37","author":"RF Johnson","year":"2012","unstructured":"Johnson RF, Perkins ND (2012) Nuclear factor-\u03baB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect. Trends Biochem Sci 37:317\u2013324","journal-title":"Trends Biochem Sci"},{"key":"1965_CR119","doi-asserted-by":"crossref","first-page":"P4","DOI":"10.1186\/1753-6561-6-S3-P4","volume":"6","author":"C Barron","year":"2012","unstructured":"Barron C, Tsiani E, Tsakiridis T (2012) Expression of the glucose transporters GLUT1, GLUT3, GLUT4 and GLUT12 in human cancer cells. BMC Proc 6:P4","journal-title":"BMC Proc"},{"key":"1965_CR120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4067\/S0716-97602002000100004","volume":"35","author":"RA Medina","year":"2002","unstructured":"Medina RA, Owen GI (2002) Glucose transporters: expression, regulation and cancer. Biol Res 35:9\u201326","journal-title":"Biol Res"},{"key":"1965_CR121","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X","volume":"72","author":"RS Brown","year":"1993","unstructured":"Brown RS, Wahl RL (1993) Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical study. Cancer 72:2979\u20132985","journal-title":"Cancer"},{"key":"1965_CR122","doi-asserted-by":"crossref","unstructured":"Haber RS, Rathan A, Weiser KR, et al (1998) GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83:34\u201340.","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E"},{"key":"1965_CR123","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7","volume":"80","author":"M Younes","year":"1997","unstructured":"Younes M, Brown RW, Stephenson M et al (1997) Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 80:1046\u20131051","journal-title":"Cancer"},{"key":"1965_CR124","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/cncr.11159","volume":"97","author":"M Kunkel","year":"2003","unstructured":"Kunkel M, Reichert TE, Benz P et al (2003) Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97:1015\u20131024","journal-title":"Cancer"},{"key":"1965_CR125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbcan.2012.06.004","volume":"1826","author":"JQ Chen","year":"2012","unstructured":"Chen JQ, Russo J (2012) Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta - Rev Cancer 1826:370\u2013384","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"key":"1965_CR126","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/febs.14125","volume":"285","author":"EM Kerr","year":"2018","unstructured":"Kerr EM, Martins CP (2018) Metabolic rewiring in mutant Kras lung cancer. FEBS J 285:28\u201341","journal-title":"FEBS J"},{"key":"1965_CR127","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","volume":"21","author":"AC Kimmelman","year":"2015","unstructured":"Kimmelman AC (2015) Metabolic dependencies in RAS-driven cancers. Clin Cancer Res 21:1828\u20131834","journal-title":"Clin Cancer Res"},{"key":"1965_CR128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2013.12.004","volume":"39","author":"KL Bryant","year":"2014","unstructured":"Bryant KL, Mancias JD, Kimmelman AC, Der CJ (2014) KRAS: feeding pancreatic cancer proliferation. Trends Biochem Sci 39:91\u2013100","journal-title":"Trends Biochem Sci"},{"key":"1965_CR129","doi-asserted-by":"crossref","first-page":"20813","DOI":"10.1074\/jbc.M114.575464","volume":"289","author":"H Makinoshima","year":"2014","unstructured":"Makinoshima H, Takita M, Matsumoto S et al (2014) Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma. J Biol Chem 289:20813\u201320823","journal-title":"J Biol Chem"},{"key":"1965_CR130","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1021\/pr500327v","volume":"13","author":"A Mart\u00edn-Bernab\u00e9","year":"2014","unstructured":"Mart\u00edn-Bernab\u00e9 A, Cort\u00e9s R, Lehmann SG et al (2014) Quantitative proteomic approach to understand metabolic adaptation in non-small cell lung cancer. J Proteome Res 13:4695\u20134704","journal-title":"J Proteome Res"},{"key":"1965_CR131","doi-asserted-by":"crossref","unstructured":"Yun J, Rago C, Cheong I, et al (2009) Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science (80- ) 325:1555\u20131559.","DOI":"10.1126\/science.1174229"},{"key":"1965_CR132","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/msb.2011.56","volume":"7","author":"D Gaglio","year":"2011","unstructured":"Gaglio D, Metallo CM, Gameiro PA et al (2011) Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol 7:523","journal-title":"Mol Syst Biol"},{"key":"1965_CR133","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.celrep.2016.09.045","volume":"17","author":"B Smith","year":"2016","unstructured":"Smith B, Schafer XL, Ambeskovic A et al (2016) Addiction to coupling of the Warburg effect with glutamine catabolism in cancer cells. Cell Rep 17:821\u2013836","journal-title":"Cell Rep"},{"key":"1965_CR134","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/0008-5472.CAN-10-1668","volume":"71","author":"X Zha","year":"2011","unstructured":"Zha X, Wang F, Wang Y et al (2011) Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res 71:13\u201318","journal-title":"Cancer Res"},{"key":"1965_CR135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.00001","volume":"9","author":"FM La","year":"2019","unstructured":"La FM, Lessi F, Aretini P et al (2019) ANKRd44 gene silencing: a putative role in trastuzumab resistance in HER2-like breast cancer. Front Oncol 9:1\u201315","journal-title":"Front Oncol"},{"key":"1965_CR136","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccell.2016.08.005","volume":"30","author":"L Brisson","year":"2016","unstructured":"Brisson L, Ba\u0144ski P, Sboarina M et al (2016) Lactate dehydrogenase B controls lysosome activity and autophagy in cancer. Cancer Cell 30:418\u2013431","journal-title":"Cancer Cell"},{"key":"1965_CR137","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ijo.2012.1537","volume":"41","author":"Y Isozaki","year":"2012","unstructured":"Isozaki Y, Hoshino I, Nohata N et al (2012) Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. Int J Oncol 41:985\u2013994","journal-title":"Int J Oncol"},{"key":"1965_CR138","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/cancers10110443","volume":"10","author":"S Kumar","year":"2018","unstructured":"Kumar S, Xie H, Scicluna P et al (2018) MiR-375 regulation of LDHB plays distinct roles in polyomavirus-positive and-negative merkel cell carcinoma. Cancers (Basel) 10:443","journal-title":"Cancers (Basel)"},{"key":"1965_CR139","first-page":"1","volume":"17","author":"KT Yuan","year":"2018","unstructured":"Yuan KT, Li BX, Yuan YJ et al (2018) Deregulation of MicroRNA-375 inhibits proliferation and migration in gastric cancer in association with autophagy-mediated AKT\/mTOR signaling pathways. Technol Cancer Res Treat 17:1\u201311","journal-title":"Technol Cancer Res Treat"},{"key":"1965_CR140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1878-0261.12408","volume":"13","author":"L Shi","year":"2019","unstructured":"Shi L, Yan H, An S et al (2019) SIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer. Mol Oncol 13:358\u2013375","journal-title":"Mol Oncol"},{"key":"1965_CR141","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","volume":"281","author":"MS Ullah","year":"2006","unstructured":"Ullah MS, Davies AJ, Halestrap AP (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1\u03b1-dependent mechanism. J Biol Chem 281:9030\u20139037","journal-title":"J Biol Chem"},{"key":"1965_CR142","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/nar\/29.2.397","volume":"29","author":"M Schuhmacher","year":"2001","unstructured":"Schuhmacher M (2001) The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res 29:397\u2013406","journal-title":"Nucleic Acids Res"},{"key":"1965_CR143","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1073\/pnas.97.7.3260","volume":"97","author":"HA Coller","year":"2000","unstructured":"Coller HA, Grandori C, Tamayo P et al (2000) Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A 97:3260\u20133265","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1965_CR144","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/0008-5472.CAN-13-2034","volume":"74","author":"JR Doherty","year":"2014","unstructured":"Doherty JR, Yang C, Scott KEN et al (2014) Blocking lactate export by inhibiting the myc target MCT1 disables glycolysis and glutathione synthesis. Cancer Res 74:908\u2013920","journal-title":"Cancer Res"},{"key":"1965_CR145","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.CAN-11-2474","volume":"72","author":"R Boidot","year":"2012","unstructured":"Boidot R, Ve\u01f5ran F, Meulle A et al (2012) Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Res 72:939\u2013948","journal-title":"Cancer Res"},{"key":"1965_CR146","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","volume":"27","author":"GA Brooks","year":"2018","unstructured":"Brooks GA (2018) The science and translation of lactate shuttle theory. Cell Metab 27:757\u2013785","journal-title":"Cell Metab"},{"key":"1965_CR147","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cmet.2018.10.011","volume":"28","author":"SM Sanderson","year":"2018","unstructured":"Sanderson SM, Locasale JW (2018) Revisiting the Warburg effect: some tumors hold their breath. Cell Metab 28:669\u2013670","journal-title":"Cell Metab"},{"key":"1965_CR148","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.trecan.2017.09.002","volume":"3","author":"E Zacksenhaus","year":"2017","unstructured":"Zacksenhaus E, Shrestha M, Liu JC et al (2017) Mitochondrial OXPHOS induced by RB1 deficiency in breast cancer: implications for anabolic metabolism, stemness, and metastasis. Trends Cancer 3:768\u2013779","journal-title":"Trends Cancer"},{"key":"1965_CR149","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley CT, Faubert B, Yuan Q et al (2016) Metabolic heterogeneity in human lung tumors. Cell 164:681\u2013694","journal-title":"Cell"},{"key":"1965_CR150","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nchembio.2172","volume":"12","author":"YJ Chen","year":"2016","unstructured":"Chen YJ, Mahieu NG, Huang X et al (2016) Lactate metabolism is associated with mammalian mitochondria. Nat Chem Biol 12:937\u2013943","journal-title":"Nat Chem Biol"},{"key":"1965_CR151","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1152\/physiolgenomics.00177.2010","volume":"43","author":"R Hussien","year":"2011","unstructured":"Hussien R, Brooks GA (2011) Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiol Genomics 43:255\u2013264","journal-title":"Physiol Genomics"},{"key":"1965_CR152","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui S, Ghergurovich JM, Morscher RJ et al (2017) Glucose feeds the TCA cycle via circulating lactate. Nature 551:115\u2013118","journal-title":"Nature"},{"key":"1965_CR153","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.celrep.2016.03.026","volume":"15","author":"S Park","year":"2016","unstructured":"Park S, Chang CY, Safi R et al (2016) ERR\u03b1-regulated lactate metabolism contributes to resistance to targeted therapies in breast cancer. Cell Rep 15:323\u2013335","journal-title":"Cell Rep"},{"key":"1965_CR154","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/onc.2014.47","volume":"34","author":"K Leithner","year":"2015","unstructured":"Leithner K, Hrzenjak A, Tr\u00f6tzm\u00fcller M et al (2015) PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Oncogene 34:1044\u20131050","journal-title":"Oncogene"},{"key":"1965_CR155","doi-asserted-by":"publisher","unstructured":"Bok R, Lee J, Sriram R et al (2019) The role of lactate metabolism in prostate cancer progression and metastases revealed by dual-agent hyperpolarized 13 C MRSI. Cancers (Basel) 11(2). https:\/\/doi.org\/10.3390\/cancers11020257","DOI":"10.3390\/cancers11020257"},{"key":"1965_CR156","first-page":"3835","volume":"118","author":"GL Semenza","year":"2008","unstructured":"Semenza GL (2008) Tumor metabolism: cancer cells give and take lactate. J Clin Invest 118:3835\u20133837","journal-title":"J Clin Invest"},{"key":"1965_CR157","doi-asserted-by":"crossref","first-page":"e75154","DOI":"10.1371\/journal.pone.0075154","volume":"8","author":"KM Kennedy","year":"2013","unstructured":"Kennedy KM, Scarbrough PM, Ribeiro A et al (2013) Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. PLoS One 8:e75154","journal-title":"PLoS One"},{"key":"1965_CR158","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.celrep.2014.11.025","volume":"9","author":"GH Baek","year":"2014","unstructured":"Baek GH, Tse YF, Hu Z et al (2014) MCT4 Defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. Cell Rep 9:2233\u20132249","journal-title":"Cell Rep"},{"key":"1965_CR159","doi-asserted-by":"crossref","first-page":"220","DOI":"10.21037\/atm.2019.02.32","volume":"7","author":"ML Goodwin","year":"2019","unstructured":"Goodwin ML, Pennington Z, Westbroek EM et al (2019) Lactate and cancer: a \u201clactatic\u201d perspective on spinal tumor metabolism (part 1). Ann Transl Med 7:220","journal-title":"Ann Transl Med"},{"key":"1965_CR160","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1158\/0008-5472.CAN-12-1098","volume":"72","author":"ML McCleland","year":"2012","unstructured":"McCleland ML, Adler AS, Shang Y et al (2012) An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer. Cancer Res 72:5812\u20135823","journal-title":"Cancer Res"},{"key":"1965_CR161","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R et al (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8:3984\u20134001","journal-title":"Cell Cycle"},{"key":"1965_CR162","doi-asserted-by":"crossref","first-page":"57813","DOI":"10.18632\/oncotarget.18175","volume":"8","author":"Y Fu","year":"2017","unstructured":"Fu Y, Liu S, Yin S et al (2017) The reverse Warburg effect is likely to be an Achilles\u2019 heel of cancer that can be exploited for cancer therapy. Oncotarget 8:57813\u201357825","journal-title":"Oncotarget"},{"key":"1965_CR163","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/bj3640309","volume":"364","author":"M Guppy","year":"2002","unstructured":"Guppy M, Leedman P, Zu XL, Russell V (2002) Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 364:309\u2013315","journal-title":"Biochem J"},{"key":"1965_CR164","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","volume":"72","author":"T Fiaschi","year":"2012","unstructured":"Fiaschi T, Marini A, Giannoni E et al (2012) Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res 72:5130\u20135140","journal-title":"Cancer Res"},{"key":"1965_CR165","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.yexcr.2011.11.014","volume":"318","author":"YI Rattigan","year":"2012","unstructured":"Rattigan YI, Patel BB, Ackerstaff E et al (2012) Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res 318:326\u2013335","journal-title":"Exp Cell Res"},{"key":"1965_CR166","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yexcr.2017.01.013","volume":"352","author":"BB Patel","year":"2017","unstructured":"Patel BB, Ackerstaff E, Serganova IS et al (2017) Tumor stroma interaction is mediated by monocarboxylate metabolism. Exp Cell Res 352:20\u201333","journal-title":"Exp Cell Res"},{"key":"1965_CR167","doi-asserted-by":"publisher","unstructured":"Mishra D, Banerjee D (2019) Lactate dehydrogenases as metabolic links between tumor and stroma in the tumor microenvironment. Cancers (Basel) 11(6). https:\/\/doi.org\/10.3390\/cancers11060750","DOI":"10.3390\/cancers11060750"},{"key":"1965_CR168","doi-asserted-by":"publisher","unstructured":"Apicella M, Giannoni E, Fiore S, et al (2018) Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies. Cell Metab 28(6):848\u2013865.e6. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.006","DOI":"10.1016\/j.cmet.2018.08.006"},{"key":"1965_CR169","doi-asserted-by":"crossref","first-page":"24061","DOI":"10.18632\/oncotarget.4448","volume":"6","author":"E Giannoni","year":"2015","unstructured":"Giannoni E, Taddei ML, Morandi A et al (2015) Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread. Oncotarget 6:24061\u201324074","journal-title":"Oncotarget"},{"key":"1965_CR170","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.18632\/oncotarget.2243","volume":"5","author":"G Bonuccelli","year":"2014","unstructured":"Bonuccelli G, Avnet S, Grisendi G et al (2014) Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells. Oncotarget 5:7575\u20137588","journal-title":"Oncotarget"},{"key":"1965_CR171","doi-asserted-by":"crossref","first-page":"18333","DOI":"10.3390\/ijms151018333","volume":"15","author":"N P\u00e9rtega-Gomes","year":"2014","unstructured":"P\u00e9rtega-Gomes N, Baltazar F (2014) Lactate transporters in the context of prostate cancer metabolism: what do we know? Int J Mol Sci 15:18333\u201318348","journal-title":"Int J Mol Sci"},{"key":"1965_CR172","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4161\/cc.10.11.15659","volume":"10","author":"D Whitaker-Menezes","year":"2011","unstructured":"Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z et al (2011) Evidence for a stromal-epithelial \u201clactate shuttle\u201d in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 10:1772\u20131783","journal-title":"Cell Cycle"},{"key":"1965_CR173","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1016\/j.biocel.2009.08.012","volume":"41","author":"N Bellance","year":"2009","unstructured":"Bellance N, Benard G, Furt F et al (2009) Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566\u20132577","journal-title":"Int J Biochem Cell Biol"},{"key":"1965_CR174","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.biocel.2010.07.010","volume":"42","author":"S Rodr\u00edguez-Enr\u00edquez","year":"2010","unstructured":"Rodr\u00edguez-Enr\u00edquez S, Carre\u00f1o-Fuentes L, Gallardo-P\u00e9rez JC et al (2010) Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma. Int J Biochem Cell Biol 42:1744\u20131751","journal-title":"Int J Biochem Cell Biol"},{"key":"1965_CR175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10863-009-9267-x","volume":"42","author":"K Smolkov\u00e1","year":"2010","unstructured":"Smolkov\u00e1 K, Bellance N, Scandurra F et al (2010) Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J Bioenerg Biomembr 42:55\u201367","journal-title":"J Bioenerg Biomembr"},{"key":"1965_CR176","first-page":"1373","volume":"55","author":"E Holm","year":"1995","unstructured":"Holm E, Hagm\u00fcller E, Staedt U et al (1995) Substrate balances across colonic carcinomas in humans. Cancer Res 55:1373\u20131378","journal-title":"Cancer Res"},{"key":"1965_CR177","first-page":"409","volume":"150","author":"S Walenta","year":"1997","unstructured":"Walenta S, Salameh A, Lyng H et al (1997) Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 150:409\u2013415","journal-title":"Am J Pathol"},{"key":"1965_CR178","first-page":"4757","volume":"55","author":"G Schwickert","year":"1995","unstructured":"Schwickert G, Walenta S, Mueller-Klieser W et al (1995) Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 55:4757\u20134759","journal-title":"Cancer Res"},{"key":"1965_CR179","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27:5904\u20135912","journal-title":"Oncogene"},{"key":"1965_CR180","doi-asserted-by":"crossref","first-page":"101042831875620","DOI":"10.1177\/1010428318756203","volume":"40","author":"F Lopes-Coelho","year":"2018","unstructured":"Lopes-Coelho F, Gouveia-Fernandes S, Serpa J (2018) Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression. Tumor Biol 40:101042831875620","journal-title":"Tumor Biol"},{"key":"1965_CR181","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2014.03.003","volume":"19","author":"H Xie","year":"2014","unstructured":"Xie H, Hanai JI, Ren JG et al (2014) Targeting lactate dehydrogenase-A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell Metab 19:795\u2013809","journal-title":"Cell Metab"},{"key":"1965_CR182","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1158\/0008-5472.CAN-11-3881","volume":"72","author":"JW Wojtkowiak","year":"2012","unstructured":"Wojtkowiak JW, Rothberg JM, Kumar V et al (2012) Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 72:3938\u20133947","journal-title":"Cancer Res"},{"key":"1965_CR183","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.RES.56.6.773","volume":"56","author":"RL Mahnensmith","year":"1985","unstructured":"Mahnensmith RL, Aronson PS (1985) The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res 56:773\u2013788","journal-title":"Circ Res"},{"key":"1965_CR184","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1152\/physiol.00016.2017","volume":"32","author":"S Sun","year":"2017","unstructured":"Sun S, Li H, Chen J, Qian Q (2017) Lactic acid: no longer an inert and end-product of glycolysis. Physiology 32:453\u2013463","journal-title":"Physiology"},{"key":"1965_CR185","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","volume":"89","author":"AF Chambers","year":"1997","unstructured":"Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260\u20131270","journal-title":"J Natl Cancer Inst"},{"key":"1965_CR186","first-page":"6020","volume":"61","author":"D Fukumura","year":"2001","unstructured":"Fukumura D, Xu L, Chen Y et al (2001) Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 61:6020\u20136024","journal-title":"Cancer Res"},{"key":"1965_CR187","first-page":"5745","volume":"56","author":"RA Gatenby","year":"1996","unstructured":"Gatenby RA, Gawlinski ET (1996) A reaction-diffusion model of cancer invasion. Cancer Res 56:5745\u20135753","journal-title":"Cancer Res"},{"key":"1965_CR188","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1189\/jlb.69.4.522","volume":"69","author":"A Lardner","year":"2001","unstructured":"Lardner A (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69:522\u2013530","journal-title":"J Leukoc Biol"},{"key":"1965_CR189","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","volume":"2","author":"N Nishida","year":"2006","unstructured":"Nishida N, Yano H, Nishida T et al (2006) Angiogenesis in cancer. Vasc Health Risk Manag 2:213\u2013219","journal-title":"Vasc Health Risk Manag"},{"key":"1965_CR190","doi-asserted-by":"publisher","unstructured":"Hunt TK, Aslam R, Hussain Z, Beckert S (2008) Lactate, with oxygen, incites angiogenesis. Adv Exp Med Biol 614:73\u201380. https:\/\/doi.org\/10.1007\/978-0-387-74911-2_9","DOI":"10.1007\/978-0-387-74911-2_9"},{"key":"1965_CR191","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/joim.12016","volume":"273","author":"F Polet","year":"2013","unstructured":"Polet F, Feron O (2013) Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. J Intern Med 273:156\u2013165","journal-title":"J Intern Med"},{"key":"1965_CR192","doi-asserted-by":"crossref","first-page":"e46571","DOI":"10.1371\/journal.pone.0046571","volume":"7","author":"CJ de Saedeleer","year":"2012","unstructured":"de Saedeleer CJ, Copetti T, Porporato PE et al (2012) Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS One 7:e46571","journal-title":"PLoS One"},{"key":"1965_CR193","doi-asserted-by":"crossref","unstructured":"Sonveaux P, Copetti T, de Saedeleer CJ, et al (2012) Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS One 7:e33418.","DOI":"10.1371\/journal.pone.0033418"},{"key":"1965_CR194","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ccell.2014.10.003","volume":"26","author":"ML Goodwin","year":"2014","unstructured":"Goodwin ML, Jin H, Straessler K et al (2014) Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment. Cancer Cell 26:851\u2013862","journal-title":"Cancer Cell"},{"key":"1965_CR195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature04808","volume":"442","author":"JL Langowski","year":"2006","unstructured":"Langowski JL, Zhang X, Wu L et al (2006) IL-23 promotes tumour incidence and growth. Nature 442:461\u2013465","journal-title":"Nature"},{"key":"1965_CR196","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.4049\/jimmunol.180.11.7175","volume":"180","author":"H Shime","year":"2008","unstructured":"Shime H, Yabu M, Akazawa T et al (2008) Tumor-secreted lactic acid promotes IL-23\/IL-17 proinflammatory pathway. J Immunol 180:7175\u20137183","journal-title":"J Immunol"},{"key":"1965_CR197","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cmet.2020.05.004","volume":"31","author":"J Zhang","year":"2020","unstructured":"Zhang J, Muri J, Fitzgerald G et al (2020) Endothelial lactate controls muscle regeneration from ischemia by inducing M2-like macrophage polarization. Cell Metab 31:1136\u20131153","journal-title":"Cell Metab"},{"key":"1965_CR198","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2008.03.017","volume":"18","author":"R Stern","year":"2008","unstructured":"Stern R (2008) Hyaluronidases in cancer biology. Hyaluronan Cancer Biol 18:275\u2013280","journal-title":"Hyaluronan Cancer Biol"},{"key":"1965_CR199","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semradonc.2004.04.004","volume":"14","author":"S Walenta","year":"2004","unstructured":"Walenta S, Mueller-Klieser WF (2004) Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14:267\u2013274","journal-title":"Semin Radiat Oncol"},{"key":"1965_CR200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0006-291X(03)00723-X","volume":"305","author":"B Formby","year":"2003","unstructured":"Formby B, Stern R (2003) Lactate-sensitive response elements in genes involved in hyaluronan catabolism. Biochem Biophys Res Commun 305:203\u2013208","journal-title":"Biochem Biophys Res Commun"},{"key":"1965_CR201","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","volume":"9","author":"VR Fantin","year":"2006","unstructured":"Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9:425\u2013434","journal-title":"Cancer Cell"},{"key":"1965_CR202","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd3504","volume":"10","author":"MG Vander Heiden","year":"2011","unstructured":"Vander Heiden MG (2011) Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10:671\u2013684","journal-title":"Nat Rev Drug Discov"},{"key":"1965_CR203","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.4218","volume":"230","author":"SYC Choi","year":"2013","unstructured":"Choi SYC, Collins CC, Gout PW, Wang Y (2013) Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol 230:350\u2013355","journal-title":"J Pathol"},{"key":"1965_CR204","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S et al (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109:3812\u20133819","journal-title":"Blood"},{"key":"1965_CR205","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL et al (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513:559\u2013563","journal-title":"Nature"},{"key":"1965_CR206","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","volume":"17","author":"X Mu","year":"2018","unstructured":"Mu X, Shi W, Xu Y et al (2018) Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer. Cell Cycle 17:428\u2013438","journal-title":"Cell Cycle"},{"key":"1965_CR207","first-page":"453","volume":"39","author":"K Goetze","year":"2011","unstructured":"Goetze K, Walenta S, Ksiazkiewicz M et al (2011) Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol 39:453\u2013463","journal-title":"Int J Oncol"},{"key":"1965_CR208","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1189\/jlb.0902451","volume":"73","author":"A Puig-Kr\u00f6ger","year":"2003","unstructured":"Puig-Kr\u00f6ger A, Mu\u00f1iz-Pello O, Selgas R et al (2003) Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucose-degradation products. J Leukoc Biol 73:482\u2013492","journal-title":"J Leukoc Biol"},{"key":"1965_CR209","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","volume":"107","author":"E Gottfried","year":"2006","unstructured":"Gottfried E, Kunz-Schughart LA, Ebner S et al (2006) Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107:2013\u20132021","journal-title":"Blood"},{"key":"1965_CR210","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain Z, Huang Y, Seth P, Sukhatme VP (2013) Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol 191:1486\u20131495","journal-title":"J Immunol"},{"key":"1965_CR211","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ijc.26410","volume":"131","author":"AN Mendler","year":"2012","unstructured":"Mendler AN, Hu B, Prinz PU et al (2012) Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation. Int J Cancer 131:633\u2013640","journal-title":"Int J Cancer"},{"key":"1965_CR212","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/bcr1988","volume":"10","author":"KW Hunter","year":"2008","unstructured":"Hunter KW, Crawford NPS, Alsarraj J (2008) Mechanisms of metastasis. Breast Cancer Res 10:S2","journal-title":"Breast Cancer Res"},{"key":"1965_CR213","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/CBM-150514","volume":"15","author":"PJ Vlachostergios","year":"2015","unstructured":"Vlachostergios PJ, Oikonomou KG, Gibilaro E, Apergis G (2015) Elevated lactic acid is a negative prognostic factor in metastatic lung cancer. Cancer Biomark 15:725\u2013734","journal-title":"Cancer Biomark"},{"key":"1965_CR214","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2174\/0929867043364711","volume":"11","author":"S Walenta","year":"2012","unstructured":"Walenta S, Schroeder T, Mueller-Klieser W (2012) Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem 11:2195\u20132204","journal-title":"Curr Med Chem"},{"key":"1965_CR215","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1158\/0008-5472.CAN-05-4193","volume":"66","author":"RA Gatenby","year":"2006","unstructured":"Gatenby RA, Gawlinski ET, Gmitro AF et al (2006) Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 66:5216\u20135223","journal-title":"Cancer Res"},{"key":"1965_CR216","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jtbi.2006.09.010","volume":"244","author":"K Smallbone","year":"2007","unstructured":"Smallbone K, Gatenby RA, Gillies RJ et al (2007) Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 244:703\u2013713","journal-title":"J Theor Biol"},{"key":"1965_CR217","first-page":"6517","volume":"54","author":"J Rozhin","year":"1994","unstructured":"Rozhin J, Sameni M, Ziegler G, Sloane BF (1994) Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 54:6517\u20136525","journal-title":"Cancer Res"},{"key":"1965_CR218","doi-asserted-by":"publisher","unstructured":"Matsubara T, DiResta GR, Kakunaga S et al (2013) Additive influence of extracellular pH, oxygen tension, and pressure on invasiveness and survival of human osteosarcoma cells. Front Oncol 3(199). https:\/\/doi.org\/10.3389\/fonc.2013.00199","DOI":"10.3389\/fonc.2013.00199"},{"key":"1965_CR219","first-page":"5865","volume":"14","author":"H Li","year":"2017","unstructured":"Li H, Qiu Z, Li F, Wang C (2017) The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncol Lett 14:5865\u20135870","journal-title":"Oncol Lett"},{"key":"1965_CR220","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.7314\/APJCP.2013.14.7.4107","volume":"14","author":"LN Li","year":"2013","unstructured":"Li LN, Zhou X, Gu Y, Yan J (2013) Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Asian Pac J Cancer Prev 14:4107\u20134113","journal-title":"Asian Pac J Cancer Prev"},{"key":"1965_CR221","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/030089161309900414","volume":"99","author":"D Schveigert","year":"2013","unstructured":"Schveigert D, Valuckas KP, Kovalcis V et al (2013) Significance of MMP-9 expression and MMP-9 polymorphism in prostate cancer. Tumori 99:523\u2013529","journal-title":"Tumori"},{"key":"1965_CR222","doi-asserted-by":"crossref","first-page":"221","DOI":"10.21037\/atm.2019.01.85","volume":"7","author":"Z Pennington","year":"2019","unstructured":"Pennington Z, Goodwin ML, Westbroek EM et al (2019) Lactate and cancer: spinal metastases and potential therapeutic targets (part 2). Ann Transl Med 7:221","journal-title":"Ann Transl Med"},{"key":"1965_CR223","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/138161206775201901","volume":"12","author":"W Wick","year":"2005","unstructured":"Wick W, Naumann U, Weller M (2005) Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12:341\u2013349","journal-title":"Curr Pharm Des"},{"key":"1965_CR224","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP (2002) Epithelial\u2013mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442\u2013454","journal-title":"Nat Rev Cancer"},{"key":"1965_CR225","doi-asserted-by":"publisher","unstructured":"Muscella A, Vetrugno C, Cossa LG, Marsigliante S (2019) TGF-\u03b21 activates RSC96 Schwann cells migration and invasion through MMP-2 and MMP-9 activities. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.14913","DOI":"10.1111\/jnc.14913"},{"key":"1965_CR226","doi-asserted-by":"crossref","first-page":"165576","DOI":"10.1016\/j.bbadis.2019.165576","volume":"1866","author":"Q Xie","year":"2020","unstructured":"Xie Q, Zhu Z, He Y et al (2020) A lactate-induced Snail\/STAT3 pathway drives GPR81 expression in lung cancer cells. Biochim Biophys Acta Mol basis Dis 1866:165576","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"1965_CR227","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-14-0319","volume":"74","author":"CL Roland","year":"2014","unstructured":"Roland CL, Arumugam T, Deng D et al (2014) Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res 74:5301\u20135310","journal-title":"Cancer Res"},{"key":"1965_CR228","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1349-7006.2011.01908.x","volume":"102","author":"H Izumi","year":"2011","unstructured":"Izumi H, Takahashi M, Uramoto H et al (2011) Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 102:1007\u20131013","journal-title":"Cancer Sci"},{"key":"1965_CR229","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2174\/138161212799504902","volume":"18","author":"S Dhup","year":"2012","unstructured":"Dhup S, Kumar Dadhich R, Ettore Porporato P, Sonveaux P (2012) Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 18:1319\u20131330","journal-title":"Curr Pharm Des"},{"key":"1965_CR230","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1158\/0008-5472.CAN-17-0764","volume":"77","author":"VL Payen","year":"2017","unstructured":"Payen VL, Hsu MY, R\u00e4decke KS et al (2017) Monocarboxylate transporter MCT1 promotes tumor metastasis independently of its activity as a lactate transporter. Cancer Res 77:5591\u20135601","journal-title":"Cancer Res"},{"key":"1965_CR231","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","volume":"577","author":"A Tasdogan","year":"2020","unstructured":"Tasdogan A, Faubert B, Ramesh V et al (2020) Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature 577:115\u2013120","journal-title":"Nature"},{"key":"1965_CR232","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0006-291X(90)92374-9","volume":"168","author":"M Maekawa","year":"1990","unstructured":"Maekawa M, Sudo K, Kanno T, Li SSL (1990) Molecular characterization of genetic mutation in human lactate dehydrogenase-A (M) deficiency. Biochem Biophys Res Commun 168:677\u2013682","journal-title":"Biochem Biophys Res Commun"},{"key":"1965_CR233","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0009-8981(88)90359-2","volume":"173","author":"T Kanno","year":"1988","unstructured":"Kanno T, Sudo K, Maekawa M et al (1988) Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy. Clin Chim Acta 173:89\u201398","journal-title":"Clin Chim Acta"},{"key":"1965_CR234","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-2952(01)00636-0","volume":"62","author":"Y Yu","year":"2001","unstructured":"Yu Y, Deck JA, Hunsaker LA et al (2001) Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4. Biochem Pharmacol 62:81\u201389","journal-title":"Biochem Pharmacol"},{"key":"1965_CR235","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/0929867003375119","volume":"7","author":"D Vander Jagt","year":"2012","unstructured":"Vander Jagt D, Deck L, Royer R (2012) Gossypol prototype of inhibitors targeted to dinucleotide folds. Curr Med Chem 7:479\u2013498","journal-title":"Curr Med Chem"},{"key":"1965_CR236","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-08-2985","volume":"15","author":"G Liu","year":"2009","unstructured":"Liu G, Kelly WK, Wilding G et al (2009) An open-label, multicenter, phase I\/II study of single-agent AT-101 in men with castrate-resistant prostate cancer. Clin Cancer Res 15:3172\u20133176","journal-title":"Clin Cancer Res"},{"key":"1965_CR237","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/JTO.0b013e3181e8f4dc","volume":"5","author":"R Suk Heist","year":"2010","unstructured":"Suk Heist R, Fain J, Chinnasami B et al (2010) Phase I\/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer. J Thorac Oncol 5:1637\u20131643","journal-title":"J Thorac Oncol"},{"key":"1965_CR238","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cmdc.201100471","volume":"7","author":"M Manerba","year":"2012","unstructured":"Manerba M, Vettraino M, Fiume L et al (2012) Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase. ChemMedChem 7:311\u2013317","journal-title":"ChemMedChem"},{"key":"1965_CR239","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1021\/jm980334n","volume":"41","author":"LM Deck","year":"1998","unstructured":"Deck LM, Royer RE, Chamblee BB et al (1998) Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum. J Med Chem 41:3879\u20133887","journal-title":"J Med Chem"},{"key":"1965_CR240","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ejps.2012.08.012","volume":"47","author":"F Farabegoli","year":"2012","unstructured":"Farabegoli F, Vettraino M, Manerba M et al (2012) Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. Eur J Pharm Sci 47:729\u2013738","journal-title":"Eur J Pharm Sci"},{"key":"1965_CR241","doi-asserted-by":"publisher","unstructured":"Doherty JR, Cleveland JL (2013) Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123(9):3685\u20133692. https:\/\/doi.org\/10.1172\/JCI69741","DOI":"10.1172\/JCI69741"},{"key":"1965_CR242","doi-asserted-by":"publisher","unstructured":"Oshima N, Ishida R, Kishimoto S et al (2020) Dynamic imaging of LDH inhibition in tumors reveals rapid in vivo metabolic rewiring and vulnerability to combination therapy. Cell Rep:1798\u20131810. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.039","DOI":"10.1016\/j.celrep.2020.01.039"},{"key":"1965_CR243","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.tp.0000287543.91765.41","volume":"84","author":"V Bueno","year":"2007","unstructured":"Bueno V, Binet I, Steger U et al (2007) The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse. Transplantation 84:1204\u20131207","journal-title":"Transplantation"},{"key":"1965_CR244","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/jm060995h","volume":"50","author":"SD Guile","year":"2007","unstructured":"Guile SD, Bantick JR, Cooper ME et al (2007) Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties. J Med Chem 50:254\u2013263","journal-title":"J Med Chem"},{"key":"1965_CR245","doi-asserted-by":"crossref","first-page":"69219","DOI":"10.18632\/oncotarget.18215","volume":"8","author":"NJ Curtis","year":"2017","unstructured":"Curtis NJ, Mooney L, Hopcroft L et al (2017) Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt\u2019s lymphoma anti-tumor activity. Oncotarget 8:69219\u201369236","journal-title":"Oncotarget"},{"key":"1965_CR246","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-018-0279-5","volume":"21","author":"X Guan","year":"2019","unstructured":"Guan X, Rodriguez-Cruz V, Morris ME (2019) Cellular uptake of MCT1 inhibitors AR-C155858 and AZD3965 and their effects on MCT-mediated transport of L-lactate in murine 4T1 breast tumor cancer cells. AAPS J 21:13","journal-title":"AAPS J"},{"key":"1965_CR247","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2015.05.015","volume":"365","author":"R Amorim","year":"2015","unstructured":"Amorim R, Pinheiro C, Miranda-Gon\u00e7alves V et al (2015) Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells. Cancer Lett 365:68\u201378","journal-title":"Cancer Lett"},{"key":"1965_CR248","doi-asserted-by":"crossref","unstructured":"Payen VL, Mina E, Van H\u00e9e VF, et al (2020) Monocarboxylate transporters in cancer. Mol Metab 33:48\u201366.","DOI":"10.1016\/j.molmet.2019.07.006"},{"key":"1965_CR249","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee Y, Morrison BM, Li Y et al (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443\u2013448","journal-title":"Nature"},{"key":"1965_CR250","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2407-14-154","volume":"14","author":"P Sanit\u00e0","year":"2014","unstructured":"Sanit\u00e0 P, Capulli M, Teti A et al (2014) Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression. BMC Cancer 14:154","journal-title":"BMC Cancer"},{"key":"1965_CR251","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/0008-5472.CAN-05-3260","volume":"66","author":"MI Koukourakis","year":"2006","unstructured":"Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66:632\u2013637","journal-title":"Cancer Res"},{"key":"1965_CR252","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.4161\/cbt.6.9.4635","volume":"6","author":"MI Koukourakis","year":"2007","unstructured":"Koukourakis MI, Giatromanolaki A, Bougioukas G, Sivridis E (2007) Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biol Ther 6:1476\u20131479","journal-title":"Cancer Biol Ther"},{"key":"1965_CR253","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/labinvest.2017.79","volume":"97","author":"MI Koukourakis","year":"2017","unstructured":"Koukourakis MI, Kalamida D, Mitrakas AG et al (2017) Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts. Lab Investig 97:1321\u20131331","journal-title":"Lab Investig"},{"key":"1965_CR254","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1242\/dmm.007724","volume":"4","author":"N Draoui","year":"2011","unstructured":"Draoui N, Feron O (2011) Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments. DMM Dis Model Mech 4:727\u2013732","journal-title":"DMM Dis Model Mech"},{"key":"1965_CR255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng.2471","volume":"45","author":"K Birsoy","year":"2013","unstructured":"Birsoy K, Wang T, Possemato R et al (2013) MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet 45:104\u2013108","journal-title":"Nat Genet"},{"key":"1965_CR256","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1124\/jpet.119.256503","volume":"370","author":"KE Follman","year":"2019","unstructured":"Follman KE, Morris ME (2019) Treatment of \u03b3-hydroxybutyric acid and \u03b3-butyrolactone overdose with two potent monocarboxylate transporter 1 inhibitors, AZD3965 and AR-C155858. J Pharmacol Exp Ther 370:84\u201391","journal-title":"J Pharmacol Exp Ther"},{"key":"1965_CR257","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/emboj\/19.15.3896","volume":"19","author":"P Kirk","year":"2000","unstructured":"Kirk P, Wilson MC, Heddle C et al (2000) CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 19:3896\u20133904","journal-title":"EMBO J"},{"key":"1965_CR258","doi-asserted-by":"crossref","first-page":"27213","DOI":"10.1074\/jbc.M411950200","volume":"280","author":"MC Wilson","year":"2005","unstructured":"Wilson MC, Meredith D, Manning Fox JE et al (2005) Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is embigin (gp70). J Biol Chem 280:27213\u201327321","journal-title":"J Biol Chem"},{"key":"1965_CR259","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbrc.2008.06.122","volume":"374","author":"M Baba","year":"2008","unstructured":"Baba M, Inoue M, Itoh K, Nishizawa Y (2008) Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism. Biochem Biophys Res Commun 374:111\u2013116","journal-title":"Biochem Biophys Res Commun"},{"key":"1965_CR260","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1136\/gut.2009.181412","volume":"58","author":"W Schneiderhan","year":"2009","unstructured":"Schneiderhan W, Scheler M, Holzmann KH et al (2009) CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models. Gut 58:1391\u20131398","journal-title":"Gut"},{"key":"1965_CR261","doi-asserted-by":"publisher","unstructured":"Doherty JR, Cleveland JL (2013) Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123(9):3685\u201392. https:\/\/doi.org\/10.1172\/JCI69741","DOI":"10.1172\/JCI69741"},{"key":"1965_CR262","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nano.2012.08.004","volume":"9","author":"VK Venishetty","year":"2013","unstructured":"Venishetty VK, Samala R, Komuravelli R et al (2013) \u03b2-Hydroxybutyric acid grafted solid lipid nanoparticles: a novel strategy to improve drug delivery to brain. Nanomed Nanotechnol Biol Med 9:388\u2013397","journal-title":"Nanomed Nanotechnol Biol Med"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01965-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-020-01965-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01965-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T11:29:34Z","timestamp":1667993374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-020-01965-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,22]]},"references-count":262,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1965"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-01965-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,22]]},"assertion":[{"value":"10 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The paper does not involve any ethical issue.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}